BNET Industries
- Public
- US
Dow Jones Description
The Company, a Utah Corporation, was incorporated on March 21, 1981. Since incorporation the Company has undergone several name, ownership, directional and management changes. In July, 1998 the Company changed its name to E-Commerce West Corp. from Royal Casino Group reflecting a shift in its primary business focus from gaming to e-Commerce. The Company changed its name to IBNG in 2001 and then changed its name to Baymark Technologies, Inc. in 2002, concurrent with a 1 for 6 reverse split of its common stock. The Company has no revenues or business operations. The Company stock traded on the OTCBB and on the "Pink Sheets" under the symbol "BYMT" in the fiscal year after fiscal year end, and after September 30, 2005, the Company symbol was changed to "BYMR" on the OTCBB. The Company maintains its principal office at 7609 Ralston Road, Arvada, CO 80002. The Company's mailing address is 7609 Ralston Road, Arvada, CO 80002, it's telephone and fax numbers are (303) 422.8127.
President, Chief Executive Officer
George W RozakisPeer Companies
NAICS Code Medical Laboratories: 621511
Decision Makers
| Name (plus bio) | Position |
|---|---|
| George W Rozakis | President, Chief Executive Officer |
| Igor Valyunin | Chief Scientific Officer |
| William Rozakis | Chief Financial Officer and Secretary |
| Alexander Hatsis | Medical Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Jerry Kaeni | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Implantable Vision, Inc. | President, Chief Executive Officer | Current |
Igor Valyunin Dr. Valyunin was Chief Biopolymer Engineer at the Dr. Federov Eye Institute (MNTK) in Moscow, Russia and a key member of the group that invented phakic refractive lenses in the 1980's. He has over 20 years of experience in developing and manufacturing the lenses and has developed and patented in conjunction with Dr. Rozakis, the design of our lens. In 1997, he held the patent on the PRL phakic lens that was licensed by International Vision, Inc. The company transferred the technology to the United States and subsequently acquired Medennium, Inc., a California manufacturing facility. The lens utilized international data to bypass Phase I FDA studies and is currently in FDA Phase III trials. The marketing rights were licensed to CIBA Novartis in the United States, and Zeiss Inc. internationally. Since that time, Igor developed a new generation of lenses, including product line extensions, to be commercialized by our company, Implantable Vision, Inc. He received his degree from the Leningrad Technology Institute in Russia with a specialization in Chemistry, technology of organic synthesis. He also remained at the university and received an MBA equivalent degree.
| Organization | Position | Status |
|---|---|---|
| Implantable Vision, Inc. | Chief Scientific Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Implantable Vision, Inc. | Chief Financial Officer and Secretary | Current |
| Vision Sensors, LLC | Current | |
| Duke University | Degree In Biomedical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| The State University of New York | Director of Refractive Surgery | Current |
| Implantable Vision, Inc. | Medical Director | Current |
| The State University of New York | Assistant Clinical Professor | Current |
| Implantable Vision, Inc. | Board of Directors | Current |
| American Academy of Ophthalmology, Inc. | Board of Directors | Current |
| American College of Surgeons | Fellow | Current |
| American Academy of Ophthalmology, Inc. | Member | Current |
| Fordham University | Bachelors of Science Degree In Biology | Former |
| Organization | Position | Status |
|---|---|---|
| Millennium Biomedical, Inc | Chief Executive Officer | Current |
| Millennium Biomedical, Inc | President | Current |
| Implantable Vision, Inc. | Board of Directors | Current |
| ESCO Corporation | Engineering Manager | Former |
| Iolab Corporation | Former |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes



